Contraindicated (1)pentobarbital will lessen the extent or result of lorlatinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. pentobarbital will decrease the level or influence of dutasteride by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unknown.